Trezix is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Wraser Llc. The primary component is Acetaminophen; .
Product ID | 66992-340_e87737f3-85f9-4e86-b66a-a59765b77611 |
NDC | 66992-340 |
Product Type | Human Prescription Drug |
Proprietary Name | Trezix |
Generic Name | Acetaminophen, Caffeine, Dihydrocodeine Bitartrate |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2009-09-01 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA040688 |
Labeler Name | WraSer LLC |
Substance Name | ACETAMINOPHEN; |
Active Ingredient Strength | 321 mg/1; mg/1; mg/ |
Pharm Classes | Central Nervous |
DEA Schedule | CIII |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2009-09-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA040688 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2009-09-01 |
Marketing End Date | 2018-12-31 |
Ingredient | Strength |
---|---|
ACETAMINOPHEN | 320.5 mg/1 |
SPL SET ID: | 63841f53-a567-4102-80b5-3565d9b52373 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
63187-705 | Trezix | acetaminophen, caffeine, dihydrocodeine bitartrate |
63629-5637 | Trezix | acetaminophen, caffeine, dihydrocodeine bitartrate |
66992-340 | Trezix | acetaminophen, caffeine, dihydrocodeine bitartrate |
66992-840 | Trezix | acetaminophen, caffeine, dihydrocodeine bitartrate |
42195-840 | Acetaminophen, Caffeine, Dihydrocodeine Bitartrate | Acetaminophen, Caffeine, Dihydrocodeine Bitartrate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TREZIX 88326471 not registered Live/Pending |
Wraser Pharmaceuticals 2019-03-05 |
TREZIX 86660330 4889095 Live/Registered |
Wraser Pharmaceuticals 2015-06-12 |
TREZIX 77101832 3463260 Dead/Cancelled |
E5 Pharma, Inc. 2007-02-07 |